Filing Details
- Accession Number:
- 0001144204-14-033539
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-05-27 06:10:56
- Reporting Period:
- 2014-05-22
- Filing Date:
- 2014-05-27
- Accepted Time:
- 2014-05-27 06:10:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 894158 | Synthetic Biologics Inc. | SYN | Pharmaceutical Preparations (2834) | 133808303 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1371742 | Evan Charles Ballantyne | C/O Synthetic Biologics, Inc., 155 Gibbs Street, Suite 412 Rockville MD 20850 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-05-22 | 10,000 | $1.35 | 10,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
